OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
A simple blood test detects over 30 types of cancers
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Subscribe To Our Newsletter & Stay Updated
